Wooshin Venture Investment Corp.
19
10M
16
0.50
0.16
- Areas of investment
Summary
Wooshin Venture Investment Corp. is the famous VC, which was founded in 1986.
We also calculated 1 valuable employee in our database.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight PeopleFund. Among the most successful fund investment fields, there are FinTech, Real Estate.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Wooshin Venture Investment Corp., startups are often financed by 500 Startups, Stic Investment, Seeds Capital. The meaningful sponsors for the fund in investment in the same round are Mirae Asset Venture Investment, Stic Investment, Seeds Capital. In the next rounds fund is usually obtained by D3 Jubilee, Shinhan Invest, STIC Ventures.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 0
- Rounds per year
- 0.50
- Follow on index
- 0.16
- Investments by industry
- Biotechnology (6)
- Pharmaceutical (6)
- Marketing (3)
- Information Technology (3)
- Real Estate (2) Show 24 more
- Investments by region
-
- South Korea (15)
- Singapore (3)
- United States (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cell Lab Med | 15 Nov 2021 | Biotechnology, Pharmaceutical, Therapeutics, Simulation | Early Stage Venture | 20M | Seoul, Seoul-t'ukpyolsi, South Korea |
| Mediintech | 13 May 2024 | Health Care, Medical Device | Early Stage Venture | 17M | Seoul, Seoul-t'ukpyolsi, South Korea |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.